cagrilintide + retatrutide vs CagriSema: The Battle Nobody's Covering retatrutide-and-cagrilintide-15mg-5mg

MAOB inhibitors bind to and inhibit MAOB, preventing dopamine degradation

Each compound targets distinct neurobiological pathwaysneurotrophism (BDNF), GABAergic modulation, neurotransmitter regulation, or sleep architecture

According to a peer-reviewed study published in PLOS ONE confirming that Semax affects the expression of genes related to the neurotrophin signaling pathway, specifically upregulating BDNF in the hippocampus, Semax significantly increases BDNF and its receptor TrkB in the rat hippocampus, with effects on both memory and neuronal resilience

The 2022 List was approved by WADAs Executive Committee (ExCo) during its meeting on 14 September 2021 and was first published on 30 September 2021